Actinium Signs Cooperative Research and Development Agreement With National Cancer Institute to Further Enhance Clinical and Non-clinical Development of Actimab-A for the Treatment of Acute Myeloid Leukemia and Other Hematologic Malignancies
Actinium Signs Cooperative Research and Development Agreement With National Cancer Institute to Further Enhance Clinical and Non-clinical Development of Actimab-A for the Treatment of Acute Myeloid Leukemia and Other Hematologic Malignancies
Actinium与美国国家癌症研究所签署合作研发协议，以进一步加强用于治疗急性髓系白血病和其他血液系统恶性肿瘤的Actimab-A的临床和非临床开发
Actinium Signs Cooperative Research and Development Agreement with National Cancer Institute to Further Enhance Clinical and Non-clinical Development of Actimab-A for the Treatment of Acute Myeloid Leukemia and Other Hematologic Malignancies
Actinium 与美国国家癌症研究所签署合作研发协议，以进一步加强用于治疗急性髓系白血病和其他血液系统恶性肿瘤的 Actimab-A 的临床和非临床开发